Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $192.48 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $70.75 | 4 | $0 (2017) |
| PFIZER INC. | $55.77 | 4 | $0 (2018) |
| Abbott Laboratories | $19.11 | 1 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.58 | 1 | $0 (2022) |
| Daiichi Sankyo Inc. | $14.31 | 1 | $0 (2017) |
| INSYS Therapeutics Inc | $13.96 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $37.69 | 2 | Abbott Laboratories ($19.11) |
| 2018 | $12.34 | 1 | PFIZER INC. ($12.34) |
| 2017 | $142.45 | 9 | Novartis Pharmaceuticals Corporation ($70.75) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Diabetes Care | ||||||
| 08/10/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Gastroenterology | ||||||
| 03/21/2018 | PFIZER INC. | SUTENT (Drug), BAVENCIO | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: ONCOLOGY;RESPIRATORY | ||||||
| 10/20/2017 | PFIZER INC. | SUTENT (Drug), XALKORI | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: ONCOLOGY;RESPIRATORY | ||||||
| 06/09/2017 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug), KISQALI, TYKERB | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: ONCOLOGY | ||||||
| 05/27/2017 | INSYS Therapeutics Inc | SUBSYS (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Breakthrough Cancer Pain | ||||||
| 04/26/2017 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: ONCOLOGY | ||||||
| 04/21/2017 | Novartis Pharmaceuticals Corporation | JADENU (Drug), PROMACTA | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: HEMATOLOGY | ||||||
| 04/16/2017 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Anemia | ||||||
| 04/03/2017 | PFIZER INC. | INLYTA (Drug), SUTENT | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: ONCOLOGY | ||||||
| 01/27/2017 | PFIZER INC. | SUTENT (Drug), INLYTA | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: ONCOLOGY;RESPIRATORY | ||||||
| 01/19/2017 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: ONCOLOGY | ||||||
About Dr. Vinod Patwardhan, M.D
Dr. Vinod Patwardhan, M.D is a Hematology & Oncology healthcare provider based in Montclair, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1114922606.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vinod Patwardhan, M.D has received a total of $192.48 in payments from pharmaceutical and medical device companies, with $37.69 received in 2022. These payments were reported across 12 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($192.48).
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Clinical Medical Laboratory
- Location Montclair, CA
- Active Since 06/20/2005
- Last Updated 01/10/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114922606
Products in Payments
- SUTENT (Drug) $43.75
- TASIGNA (Drug) $28.12
- JADENU (Drug) $24.42
- FREESTYLE LIBRE (Device) $19.11
- XIFAXAN (Drug) $18.58
- AFINITOR (Drug) $18.21
- INJECTAFER (Drug) $14.31
- SUBSYS (Drug) $13.96
- INLYTA (Drug) $12.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.